# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-24-046312
Filing Date
2024-11-13
Accepted
2024-11-13 07:30:32
Documents
74
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | ef20037228_10q.htm iXBRL | 10-Q | 1214893
2 | EXHIBIT 31.1 | ef20037228_ex31-1.htm | EX-31.1 | 8854
3 | EXHIBIT 31.2 | ef20037228_ex31-2.htm | EX-31.2 | 8883
4 | EXHIBIT 32.1 | ef20037228_ex32-1.htm | EX-32.1 | 6477
5 | EXHIBIT 32.2 | ef20037228_ex32-2.htm | EX-32.2 | 6378
11 |  | image0.jpg | GRAPHIC | 164126
12 |  | image00001.jpg | GRAPHIC | 24669
13 |  | image3.jpg | GRAPHIC | 56500
14 |  | image00007.jpg | GRAPHIC | 115850
15 |  | image00008.jpg | GRAPHIC | 59059
16 |  | image00009.jpg | GRAPHIC | 52549
17 |  | image00010.jpg | GRAPHIC | 23269
18 |  | image00011.jpg | GRAPHIC | 30827
| Complete submission text file | 0001140361-24-046312.txt |  | 6838563

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | grce-20240930.xsd | EX-101.SCH | 35182
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | grce-20240930_cal.xml | EX-101.CAL | 36791
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | grce-20240930_def.xml | EX-101.DEF | 189881
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | grce-20240930_lab.xml | EX-101.LAB | 513195
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | grce-20240930_pre.xml | EX-101.PRE | 295762
77 | EXTRACTED XBRL INSTANCE DOCUMENT | ef20037228_10q_htm.xml | XML | 803727

Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-322-1602
Grace Therapeutics, Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35776 | Film No.: 241451182
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)